Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


30.04.2018

1 Acta Cytol
1 Ann Oncol
1 Ann Surg
1 Anticancer Res
1 BMC Cancer
3 Br J Cancer
4 Breast Cancer
6 Breast Cancer Res Treat
5 Breast J
1 Cancer Lett
2 Cancer Res
1 Cell
2 Clin Breast Cancer
3 Clin Cancer Res
3 Eur J Surg Oncol
1 Exp Cell Res
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Nucl Med
1 Lancet Oncol
1 Nature
2 Oncogene
3 Oncol Rep
2 Oncology (Williston Park)
3 PLoS One
9 Radiology
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. MALHONE C, Longatto-Filho A, Filassi JR
    Is Human Papilloma Virus Associated with Breast Cancer? A Review of the Molecular Evidence.
    Acta Cytol. 2018 Apr 25:1-12. doi: 10.1159/000487700.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. LOIBL S, Majewski I, Guarneri V, Nekljudova V, et al
    PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.
    Ann Oncol. 2018 Apr 26. pii: 4986930. doi: 10.1093.
    PubMed     Text format    


    Ann Surg

  3. FITZAL F, Bjelic-Radisic V, Knauer M, Steger G, et al
    Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
    Ann Surg. 2018 Apr 24. doi: 10.1097/SLA.0000000000002771.
    PubMed     Text format     Abstract available


    Anticancer Res

  4. YU JK, Yue CH, Pan YR, Chiu YW, et al
    Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition via Down-regulation of EGFR Pathway in MDA-MB-231 cells.
    Anticancer Res. 2018;38:2127-2135.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. HUANG S, Murphy L, Xu W
    Genes and functions from breast cancer signatures.
    BMC Cancer. 2018;18:473.
    PubMed     Text format     Abstract available


    Br J Cancer

  6. LIIKANEN JS, Leidenius MH, Joensuu H, Vironen JH, et al
    Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study.
    Br J Cancer. 2018 Apr 24. pii: 10.1038/s41416-018-0052.
    PubMed     Text format     Abstract available

  7. ORECCHIONI S, Talarico G, Labanca V, Calleri A, et al
    Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma.
    Br J Cancer. 2018 Apr 26. pii: 10.1038/s41416-018-0076.
    PubMed     Text format     Abstract available

  8. BHARTI R, Dey G, Das AK, Mandal M, et al
    Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer.
    Br J Cancer. 2018 Apr 26. pii: 10.1038/s41416-018-0078.
    PubMed     Text format     Abstract available


    Breast Cancer

  9. AOYAGI T, Takabe K, Tamanuki T, Matsubara H, et al
    Pseudocirrhosis after chemotherapy in breast cancer, case reports.
    Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0865.
    PubMed     Text format     Abstract available

  10. WANG NN, Yang ZJ, Wang X, Chen LX, et al
    A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.
    Breast Cancer. 2018 Apr 25. pii: 10.1007/s12282-018-0863.
    PubMed     Text format     Abstract available

  11. SAKAI H, Tsurutani J, Iwasa T, Komoike Y, et al
    HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.
    Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0861.
    PubMed     Text format     Abstract available

  12. KWAPISZ D
    Cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive early breast cancer: preliminary results and ongoing studies.
    Breast Cancer. 2018 Apr 26. pii: 10.1007/s12282-018-0864.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  13. HACKETT J, Thorneloe R, Side L, Wolf M, et al
    Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.
    Breast Cancer Res Treat. 2018 Apr 24. pii: 10.1007/s10549-018-4775.
    PubMed     Text format     Abstract available

  14. SOPIK V, Narod SA
    The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.
    Breast Cancer Res Treat. 2018 Apr 24. pii: 10.1007/s10549-018-4796.
    PubMed     Text format     Abstract available

  15. HAQUE W, Verma V, Hatch S, Suzanne Klimberg V, et al
    Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2018 Apr 24. pii: 10.1007/s10549-018-4801.
    PubMed     Text format     Abstract available

  16. BACHAND J, Soulos PR, Herrin J, Pollack CE, et al
    Physician peer group characteristics and timeliness of breast cancer surgery.
    Breast Cancer Res Treat. 2018 Apr 24. pii: 10.1007/s10549-018-4789.
    PubMed     Text format     Abstract available

  17. VOCI A, Lee D, Ho E, Crane-Okada R, et al
    Impact of port site scar on perception of patients with breast cancer: patient-reported outcomes.
    Breast Cancer Res Treat. 2018 Apr 24. pii: 10.1007/s10549-018-4790.
    PubMed     Text format     Abstract available

  18. SHIMA H, Kida K, Adachi S, Yamada A, et al
    Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness.
    Breast Cancer Res Treat. 2018 Apr 24. pii: 10.1007/s10549-018-4793.
    PubMed     Text format     Abstract available


    Breast J

  19. MURATA T, Jinno H, Takahashi M, Shimoda M, et al
    Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrence.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13033.
    PubMed     Text format     Abstract available

  20. LARSON KE, Grobmyer SR, Valente SA
    Evaluation of recurrence patterns and survival in modern series of young women with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13041.
    PubMed     Text format     Abstract available

  21. JIANG Z, Yang Y, Li S, Pan Z, et al
    A case of tonsillar metastasis from breast cancer and literature review.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13045.
    PubMed     Text format    

  22. KAIDAR-PERSON O, Marks LB, Jones EL
    Pentoxifylline and vitamin E for treatment or prevention of radiation-induced fibrosis in patients with breast cancer.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13044.
    PubMed     Text format     Abstract available

  23. SCHNAPPER G, Marotti L, Casella D, Mano MP, et al
    Data managers: A survey of the European Society of Breast Cancer Specialists in certified multi-disciplinary breast centers.
    Breast J. 2018 Apr 23. doi: 10.1111/tbj.13043.
    PubMed     Text format     Abstract available


    Cancer Lett

  24. GELSOMINO L, Panza S, Giordano C, Barone I, et al
    Mutations in the Estrogen Receptor Alpha Hormone Binding Domain Promote Stem Cell Phenotype through Notch Activation in Breast Cancer Cell Lines.
    Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30290.
    PubMed     Text format     Abstract available


    Cancer Res

  25. AVANZATO D, Pupo E, Ducano N, Isella C, et al
    High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis.
    Cancer Res. 2018 Apr 24. pii: 0008-5472.CAN-17-3018.
    PubMed     Text format     Abstract available

  26. ZHENG YZ, Xue MZ, Shen HJ, Li XG, et al
    PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression.
    Cancer Res. 2018 Apr 26. pii: 0008-5472.CAN-17-3514.
    PubMed     Text format     Abstract available


    Cell

  27. KIM C, Gao R, Sei E, Brandt R, et al
    Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing.
    Cell. 2018 Apr 13. pii: S0092-8674(18)30365-9. doi: 10.1016/j.cell.2018.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  28. MORRIS PG, Rota S, Cadoo K, Zamora S, et al
    Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30810.
    PubMed     Text format     Abstract available

  29. REINERT T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, et al
    The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Mar 12. pii: S1526-8209(18)30026.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  30. SPRING L, Bardia A
    Cycling Towards Progress: Ribociclib, CDK 4/6 inhibitor for Breast Cancer.
    Clin Cancer Res. 2018 Apr 23. pii: 1078-0432.CCR-18-0463.
    PubMed     Text format     Abstract available

  31. VISSER LL, Elshof LE, Schaapveld M, Van de Vijver K, et al
    Clinicopathological risk factors for an invasive breast cancer recurrence after ductal carcinoma in situ - A nested case-control study.
    Clin Cancer Res. 2018 Apr 23. pii: 1078-0432.CCR-18-0201.
    PubMed     Text format     Abstract available

  32. GOODMAN CR, Seagle BL, Kocherginsky M, Donnelly ED, et al
    21-gene recurrence score assay predicts benefit of post-mastectomy radiotherapy in T1-2 N1 breast cancer.
    Clin Cancer Res. 2018 Apr 23. pii: 1078-0432.CCR-17-3169.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  33. JANSSEN NNY, van la Parra RFD, Loo CE, Groen EJ, et al
    Breast conserving surgery for extensive DCIS using multiple radioactive seeds.
    Eur J Surg Oncol. 2018;44:67-73.
    PubMed     Text format     Abstract available

  34. NIINIKOSKI L, Hukkinen K, Leidenius MHK, Stahls A, et al
    Breast Lesion Excision System in the diagnosis and treatment of intraductal papillomas - A feasibility study.
    Eur J Surg Oncol. 2018;44:59-66.
    PubMed     Text format     Abstract available

  35. AHN SK, Han W, Moon HG, Kim MK, et al
    Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy.
    Eur J Surg Oncol. 2018;44:53-58.
    PubMed     Text format     Abstract available


    Exp Cell Res

  36. ROYSTON KJ, Paul B, Nozell S, Rajbhandari R, et al
    Withaferin A and Sulforaphane Regulate Breast Cancer Cell Cycle Progression through Epigenetic Mechanisms.
    Exp Cell Res. 2018 Apr 21. pii: S0014-4827(18)30226.
    PubMed     Text format     Abstract available


    Int J Cancer

  37. AL-AWADHI A, Murray JL, Ibrahim NK
    Developing Anti-HER2 Vaccines: Breast Cancer Experience.
    Int J Cancer. 2018 Apr 25. doi: 10.1002/ijc.31551.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  38. TSENG YD, Cutter DJ, Plastaras JP, Parikh RR, et al
    Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017 Sep 21. pii: S0360-3016(17)30901.
    PubMed     Text format    


    J Clin Oncol

  39. SHERMAN KA, Przezdziecki A, Alcorso J, Kilby CJ, et al
    Reducing Body Image-Related Distress in Women With Breast Cancer Using a Structured Online Writing Exercise: Results From the My Changed Body Randomized Controlled Trial.
    J Clin Oncol. 2018 Apr 24:JCO2017763318. doi: 10.1200/JCO.2017.76.3318.
    PubMed     Text format     Abstract available

  40. HAMOOD R, Hamood H, Merhasin I, Keinan-Boker L, et al
    Diabetes After Hormone Therapy in Breast Cancer Survivors: A Case-Cohort Study.
    J Clin Oncol. 2018 Apr 24:JCO2017763524. doi: 10.1200/JCO.2017.76.3524.
    PubMed     Text format     Abstract available


    J Nucl Med

  41. WU J, Wang S, Zhang X, Teng Z, et al
    (18)F-Alfatide II PET/CT for Identification of Breast Cancer: A Preliminary Clinical Study.
    J Nucl Med. 2018 Apr 26. pii: jnumed.118.208637. doi: 10.2967/jnumed.118.208637.
    PubMed     Text format     Abstract available


    Lancet Oncol

  42. SCHAFER R, Strnad V, Polgar C, Uter W, et al
    Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Lancet Oncol. 2018 Apr 20. pii: S1470-2045(18)30195.
    PubMed     Text format     Abstract available


    Nature

  43. CARDOSO F, Curigliano G
    A rude awakening from tumour cells.
    Nature. 2018;554:35-36.
    PubMed     Text format    


    Oncogene

  44. TOOSI BM, El Zawily A, Truitt L, Shannon M, et al
    EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
    Oncogene. 2018 Apr 27. pii: 10.1038/s41388-018-0228.
    PubMed     Text format     Abstract available

  45. BLANCHETTE-FARRA N, Kita D, Konstorum A, Tesfay L, et al
    Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
    Oncogene. 2018 Apr 26. pii: 10.1038/s41388-018-0243.
    PubMed     Text format     Abstract available


    Oncol Rep

  46. CALAF GM, Ponce-Cusi R, Abarca-Quinones J
    Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
    Oncol Rep. 2018 Apr 20. doi: 10.3892/or.2018.6386.
    PubMed     Text format     Abstract available

  47. WANG X, Qiu H, Tang R, Song H, et al
    miR30a inhibits epithelialmesenchymal transition and metastasis in triplenegative breast cancer by targeting ROR1.
    Oncol Rep. 2018 Apr 18. doi: 10.3892/or.2018.6379.
    PubMed     Text format     Abstract available

  48. WANG Y, Zhang Z, Wang J
    MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1.
    Oncol Rep. 2018 Apr 20. doi: 10.3892/or.2018.6385.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  49. FLEMING GF, Rajagopal P
    Point: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients.
    Oncology (Williston Park). 2018;32:168-70.
    PubMed     Text format    

  50. POORVU PD, Partridge AH
    Counterpoint: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients.
    Oncology (Williston Park). 2018;32:168.
    PubMed     Text format    


    PLoS One

  51. TISSIER R, Houwing-Duistermaat J, Rodriguez-Girondo M
    Improving stability of prediction models based on correlated omics data by using network approaches.
    PLoS One. 2018;13:e0192853.
    PubMed     Text format     Abstract available

  52. PARISE C, Caggiano V
    The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.
    PLoS One. 2018;13:e0196134.
    PubMed     Text format     Abstract available

  53. DEWALD JH, Cavdarli S, Steenackers A, Delannoy CP, et al
    TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
    PLoS One. 2018;13:e0196369.
    PubMed     Text format     Abstract available


    Radiology

  54. BOEHM-STURM P, Haeckel A, Hauptmann R, Mueller S, et al
    Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
    Radiology. 2017 Jan 7:170116. doi: 10.1148/radiol.2017170116.
    PubMed     Text format     Abstract available

  55. CONANT EF, Sprague BL, Kontos D
    Beyond BI-RADS Density: A Call for Quantification in the Breast Imaging Clinic.
    Radiology. 2018;286:401-404.
    PubMed     Text format    

  56. DIPRETE O, Lourenco AP, Baird GL, Mainiero MB, et al
    Screening Digital Mammography Recall Rate: Does It Change with Digital Breast Tomosynthesis Experience?
    Radiology. 2017 Nov 28:170517. doi: 10.1148/radiol.2017170517.
    PubMed     Text format     Abstract available

  57. WEIGEL S, Khil L, Hense HW, Decker T, et al
    Detection Rates of Ductal Carcinoma in Situ with Biannual Digital Mammography Screening: Radiologic Findings Support Pathologic Model of Tumor Progression.
    Radiology. 2017 Nov 6:170673. doi: 10.1148/radiol.2017170673.
    PubMed     Text format     Abstract available

  58. LEE SH, Yi A, Jang MJ, Chang JM, et al
    Supplemental Screening Breast US in Women with Negative Mammographic Findings: Effect of Routine Axillary Scanning.
    Radiology. 2017 Oct 30:171218. doi: 10.1148/radiol.2017171218.
    PubMed     Text format     Abstract available

  59. RAY KM, Kerlikowske K, Lobach IV, Hofmann MB, et al
    Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Radiology. 2017 Oct 25:170811. doi: 10.1148/radiol.2017170811.
    PubMed     Text format     Abstract available

  60. VREEMANN S, Gubern-Merida A, Schlooz-Vries MS, Bult P, et al
    Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
    Radiology. 2017 Oct 16:170458. doi: 10.1148/radiol.2017170458.
    PubMed     Text format     Abstract available

  61. BAHL M, Barzilay R, Yedidia AB, Locascio NJ, et al
    High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision.
    Radiology. 2018;286:810-818.
    PubMed     Text format     Abstract available

  62. CHAMMING'S F, Ueno Y, Ferre R, Kao E, et al
    Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
    Radiology. 2017 Oct 4:170143. doi: 10.1148/radiol.2017170143.
    PubMed     Text format     Abstract available


    Radiother Oncol

  63. STRNAD V, Major T, Polgar C, Lotter M, et al
    ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Radiother Oncol. 2018 Apr 21. pii: S0167-8140(18)30197.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: